Fermenta Biotech Limited (BOM:506414)

Fermenta Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	518.66	282.4	218.29	352.91	130.56	167.94
Short-Term Investments	-	424.2	379.95	247.68	126.37	195.73
Cash & Short-Term Investments	518.66	706.59	598.24	600.59	256.93	363.67
Cash Growth	40.74%	18.11%	-0.39%	133.75%	-29.35%	168.82%
Accounts Receivable	1,184	1,041	729.75	448.69	870.9	680.15
Other Receivables	-	153.18	9.39	3.51	79.03	106.04
Receivables	1,195	1,205	785.78	462.45	950.08	833.85
Inventory	1,394	1,329	890.75	1,312	1,733	1,709
Prepaid Expenses	-	23.27	51.7	26.77	27.85	21.67
Restricted Cash	-	-	0	3.84	0.13	0.09
Other Current Assets	253.11	88.96	91.07	125.02	172.01	168.3
Total Current Assets	3,360	3,352	2,418	2,530	3,140	3,096
Property, Plant & Equipment	2,354	2,322	2,535	2,585	2,373	2,194
Long-Term Investments	4.66	4.86	4.43	3.76	48.93	2.49
Goodwill	41.17	41.17	41.17	115.3	109.55	107.14
Other Intangible Assets	23.37	29.98	71.55	132.72	175.95	210.09
Long-Term Deferred Tax Assets	238.25	286.44	219.99	332.58	359.94	403.1
Long-Term Deferred Charges	-	0.82	1.15	-	0.16	0.5
Other Long-Term Assets	490.49	105.38	184.8	664.14	860.34	856.93
Total Assets	6,514	6,145	5,478	6,365	7,068	6,871
Accounts Payable	807.28	774.87	649.04	457.95	645.8	621.37
Accrued Expenses	-	49.94	81.86	40	68.96	100.92
Short-Term Debt	-	812.4	673.42	1,015	974.75	963
Current Portion of Long-Term Debt	941.33	131.13	223.93	318	239.88	225.86
Current Portion of Leases	11.71	10.92	9.58	6.87	10.7	11.62
Current Income Taxes Payable	36.81	44.11	3.41	3.25	3.2	3.2
Current Unearned Revenue	11	190.09	3	0.95	-	-
Other Current Liabilities	430.04	105.31	88.36	245.6	127.94	167.37
Total Current Liabilities	2,238	2,119	1,733	2,087	2,071	2,093
Long-Term Debt	127.51	150.48	425.36	835.89	1,147	1,104
Long-Term Leases	38.44	44.44	55.39	19.91	19.68	17
Pension & Post-Retirement Benefits	-	41.38	25.62	21.43	18.85	12.74
Other Long-Term Liabilities	254.67	204.54	387.7	275.1	97.32	40.36
Total Liabilities	2,659	2,560	2,627	3,240	3,354	3,268
Common Stock	145.48	145.85	144.37	144.29	144.24	144.24
Additional Paid-In Capital	-	171.23	23.69	15.28	-	-
Retained Earnings	-	3,628	2,903	3,169	3,618	3,538
Comprehensive Income & Other	3,762	-318.36	-182.93	-174.98	-41.28	-76.73
Total Common Equity	3,908	3,627	2,889	3,153	3,721	3,606
Minority Interest	-52.39	-41.57	-36.98	-27.49	-6.83	-2.96
Shareholders' Equity	3,855	3,585	2,852	3,126	3,715	3,603
Total Liabilities & Equity	6,514	6,145	5,478	6,365	7,068	6,871
Total Debt	1,119	1,149	1,388	2,195	2,392	2,322
Net Cash (Debt)	-600.33	-442.76	-789.44	-1,595	-2,135	-1,958
Net Cash Per Share	-20.44	-15.18	-27.34	-55.26	-73.61	-67.51
Filing Date Shares Outstanding	29.13	29.43	29.43	28.86	28.85	28.85
Total Common Shares Outstanding	29.13	29.43	29.43	28.86	28.85	28.85
Working Capital	1,122	1,234	684.93	443.05	1,069	1,003
Book Value Per Share	134.13	123.23	98.15	109.27	129.00	125.00
Tangible Book Value	3,843	3,556	2,776	2,905	3,436	3,289
Tangible Book Value Per Share	131.92	120.81	94.32	100.67	119.10	114.00
Land	-	3.43	3.43	3.43	3.43	3.43
Buildings	-	1,010	1,007	717.57	701.21	564.73
Machinery	-	2,140	2,101	1,892	1,799	1,379
Construction In Progress	-	159.07	16.16	419.03	298.93	527.01
Leasehold Improvements	-	59.13	211.64	211.64	49.86	44.75

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.